Data / Form D filings / Pluton Biosciences, Inc.
Pluton Biosciences, Inc.: Form D filings
Pluton Biosciences, Inc., a biotechnology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on June 2, 2023, reports $17.6 million sold of a $17.6 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11754 WESTLINE INDUSTRIAL DRIVE, St. Louis, MO, 63146
- Phone
- (800) 688-9144
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1759355
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | New notice | $17,579,071 | $17,579,071 | 12 | Feb 24, 2023 | sec.gov | |
| Oct 1, 2021 | New notice | $6,682,968 | $6,682,968 | 38 | Sep 17, 2021 | sec.gov | |
| Jan 2, 2019 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gerald Steiner | Director | |
| Charles Lin | Director | |
| Elizabeth Gallegos | Executive Officer, Director | |
| Neal Gutterson | Director | |
| Clay Mitchell | Director | |
| Barry Goldman | Executive Officer, Director | |
| Michael Gillespie | Director |
Every Form D from the week of May 29, 2023 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pluton Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.